“With the Delta variant now the dominant strain in many places worldwide and posing a higher risk of hospitalisation than previous variants seen in the UK, it is reassuring to see that vaccination offers such high protection from death very shortly after the second dose,” said Professor Aziz Sheikh, Director of the University of Edinburgh’s Usher Institute, and EAVE II study lead.
